JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert T. Miyagishima
Michael T. Janusz
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, W.R. E.
Right arrow Articles by Ling, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamieson, W.R. E.
Right arrow Articles by Ling, H.

J Thorac Cardiovasc Surg 2005;130:994-1000
© 2005 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years

W.R. Eric Jamieson, MD * , Lawrence H. Burr, MD, Robert T. Miyagishima, MD, Eva Germann, MSc, Joan S. MacNab, Elizabeth Stanford, BScN, Florence Chan, Michael T. Janusz, MD, Hilton Ling, MD

Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada

Presented before the Society for Heart Valve Disease, Paris, France, 2003, and the European Association of Cardio-Thoracic Surgery, Vienna, Austria, 2003.

Received for publication October 22, 2004; revisions received March 4, 2005; accepted for publication March 23, 2005.

* Address for reprints: W. R. Eric Jamieson, MD, 486 Burrard Building, St Paul's Hospital, 1081 Burrard St, Vancouver, BC, Canada V6Z 1Y6 (Email: wrej{at}interchange.ubc.ca).

OBJECTIVE: Experience with the Carpentier-Edwards supra-annular porcine bioprosthesis (Edwards Lifesciences, Irvine, Calif) has been evaluated longitudinally over 20 years. Clinical performance was evaluated by actuarial and actual analysis. Hemodynamic performance was evaluated by echocardiographic/Doppler assessment. Morphology of structural failure was evaluated from pathologic examinations.

METHODS: From 1981 through 1999, 1823 patients (mean age, 68.9 ± 10.9 years; range, 19-89 years) underwent 1847 procedures. Concomitant coronary artery bypass was performed in 788 (42.7%) patients. Previous valve procedures were performed in 107 (5.8%) patients, and other cardiac procedures were performed in 87 (4.7%) patients.

RESULTS: The overall valve-related complication rate was 4.36% per patient-year (630 patients), with a fatality rate of 0.96% per patient-year (139 patients). Patient survival at 18 years was 15.8% ± 1.6%. Overall late mortality rate was 6.3% per patient-year. Overall actual cumulative freedom at 18 years from reoperation was 85.0% ± 1.2%, valve-related mortality was 88.7% ± 1.1%, and valve-related residual morbidity was 96.3% ± 5.0%. Actual freedom from structural valve deterioration at 18 years was 86.4% ± 1.2% overall, 90.5% ± 1.8% for age 61 to 70 years, and 98.2% ± 0.6% for age greater than 70 years. Structural valve deterioration presented with pathologic evidence consistent with stenosis in 27.6% and insufficiency in 72.4%. Hemodynamic performance at 1 year revealed normal effective orifice area indexes for sizes 23 to 27 mm and mild-to-moderate reduction for size 21 mm.

CONCLUSIONS: The Carpentier-Edwards supra-annular aortic porcine bioprosthesis continues to provide excellent freedom from structural valve deterioration and overall freedom from valve-related residual morbidity, mortality, and reoperation up to 18 years. Hemodynamic performance is satisfactory. The prosthesis remains recommended for patients older than 70 years and for patients 61 to 70 years of age, especially when comorbid risk factors are not anticipated to provide extended survival.





This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
W. B. Eichinger, I. M. Hettich, D. J. Ruzicka, K. Holper, C. Schricker, S. Bleiziffer, and R. Lange
Twenty-year experience with the st. Jude medical biocor bioprosthesis in the aortic position.
Ann. Thorac. Surg., October 1, 2008; 86(4): 1204 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A.C. Ennker, A. A. Albert, U. P. Rosendahl, I. C. Ennker, F. Dalladaku, and I. Florath
Ten-Year Experience With Stentless Aortic Valves: Full-Root Versus Subcoronary Implantation
Ann. Thorac. Surg., February 1, 2008; 85(2): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ruel, V. Chan, P. Bedard, A. Kulik, L. Ressler, B. K. Lam, F. D. Rubens, W. Goldstein, P. J. Hendry, R. G. Masters, et al.
Very Long-Term Survival Implications of Heart Valve Replacement With Tissue Versus Mechanical Prostheses in Adults <60 Years of Age
Circulation, September 11, 2007; 116(11_suppl): I-294 - I-300.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. W.A. van Geldorp, W.R. E. Jamieson, A. P. Kappetein, J. P.A. Puvimanasinghe, M. J.C. Eijkemans, G. L. Grunkemeier, J. J.M. Takkenberg, and A. J.J.C. Bogers
Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier Edwards supra-annular valve
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 702 - 709.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. H.L. Tang, M. Maganti, T. E. David, C. M. Feindel, H. E. Scully, and M. A. Borger
Effect of Prior Valve Type on Mortality in Reoperative Valve Surgery
Ann. Thorac. Surg., March 1, 2007; 83(3): 938 - 945.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Lau, W.R. E. Jamieson, C. Hughes, E. Germann, and F. Chan
What Prosthesis Should Be Used at Valve Re-Replacement After Structural Valve Deterioration of a Bioprosthesis?
Ann. Thorac. Surg., December 1, 2006; 82(6): 2123 - 2132.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Rizzoli, S. Mirone, P. Ius, E. Polesel, T. Bottio, L. Salvador, C. Zussa, G. Gerosa, and C. Valfre
Fifteen-year results with the Hancock II valve: A multicenter experience.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 602 - 609.e4.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
W. E. Jamieson, E. Germann, M. R Aupart, P. H Neville, M. A Marchand, and G. J Fradet
15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
Asian Cardiovasc Thorac Ann, June 1, 2006; 14(3): 200 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Chan, W.R.E. Jamieson, E. Germann, F. Chan, R.T. Miyagishima, L.H. Burr, M.T. Janusz, H. Ling, and G.J. Fradet
Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement
J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1267 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. P.A. Puvimanasinghe, J. J.M. Takkenberg, M. J.C. Eijkemans, L. A. van Herwerden, W.R. E. Jamieson, G. L. Grunkemeier, J. D. F. Habbema, and A. J.J.C. Bogers
Comparison of Carpentier-Edwards pericardial and supraannular bioprostheses in aortic valve replacement
Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 374 - 379.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.